bpc 157 ulcerative colitis clinical trial phase ii 2 of Anti-TL1A Monoclonal Antibody Tulisokibart for The Stable Gastric Pentadecapeptide BPC
Description
This interaction may increase the side effects of digoxin
Ask about our advanced peptide protocols
10.1177/1745691617718356 Perspect
It solves a long-standing problem and opens up new avenues for discovery, particularly in understanding how this powerful peptide can systemically influence health from within the GI tract
doi:10.7759/cureus.2999 6
